Kind Attn: Purchase Department
Dear Sir,
Good Afternoon,
We would like to introduce ourselves as a specialized manufacturer of API's and its key intermediates, which are manufactured at our FDA, GMP approved and ISO 9001:2000 certified plant.
We have visited your website & have understood that you are in the market of Pharmaceutical Products. In this regards, we would like to offer you our wide range of API's & their intermediates for your market.
Please find below our List of API’s & Intermediates for your ready reference.
LIST OF API’s
PRODUCT NAME DMF STATUS PRODUCT NAME DMF STATUS
CARDIOVASCULAR GASTROINTESTINAL
Amlodipine Besilate EP
Amlodipine Maleate EDMF ready
- Esomeprazole Magnesium
Trihydrate Powder / Pellets -
Clopidogrel Bisulphate USP - Lansoprazole Powder USP / Pellets EDMF ready
Enalapril Maleate USP - Omeprazole Powder USP / Pellets -
Trimetazidine Hydrochloride
JP/EP EDMF & CTD ready
ANTI FUNGAL ANTI ASTHAMATIC /
ANTI INFLAMMATORY
Fluconazole EP/USP EDMF & CTD ready Fluticasone Propionate EP -
Itraconazole EP EDMF ready Formoterol Fumarate EP EDMF ready
Ketoconazole USP EDMF ready Montelukast Sodium -
Salmeterol Xinafoate EP -
ANTI HISTAMINE ERECTILE DYSFUNCTION
Cetirizine Hydrochloride EP EDMF & CTD ready Sildenafil Citrate EDMF ready
Levocetirizine Hydrochloride - Tadalafil -
Loratadine USP EDMF ready Vardenafil Hydrochloride -
ANTI OSTEOPOROSIS ANTI DIABETIC
Etidronate Disodium USP - Glibenclamide EP EDMF ready
Ibandronate Sodium
Monohydrate - Rosiglitazone Maleate -
Pamidronate Disodium
Pentahydrate USP -
Risedronate Sodium
Hemipentahydrate/Monohydrate - OTHERS
Sodium Alendronate EP EDMF & CTD ready Sertraline Hydrochloride -
Zolidronic Acid - Tramadol Hydrochloride EP EDMF & CTD ready
LIST OF INTERMEDIATES
INTERMEDIATES CAS# USES
2,4-Difluoro-2-(1H-1,2,4-Triazole-1-YL) Acetophenone (DFTA) [86404-63-9] (Fluconazole Int.)
Tri Methyl Sulphoxonium Iodide (TMSI) [1774-47-6] (Fluconazole Int.)
2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]- Phenyl]2-(1-methylpropyl)-3H-1,2,4-triazole [106461-40-0] (Itraconazole Int.)
Cis-[2-(2,4-Dichloro Phenyl)-2 (1H-1,2,4 Triazole-l-yl methyl)-1,3-Dioxalane-4yl]methyl Methane Sulphonate [67914-86-7] (Itraconazole Int.)
Cis-[(2-Bromo methyl)-2-(2,4 dichloro phenyl)- 1,3Dioxolan-4yl methyl] benzoate (Cis Bromo Benzoate) [61397-56-6] (Itraconazole/
Ketoconazole Int.)
Cis-2-(2,4-Dichlorophenyl)-2-(1H-Imidazole-1-yl-methyl- 1,3-Dioxalan-4-yl)Methyl-P-Tolyl Sulphonate (Cis Tosylate) [134071-44-6] (Ketoconazole Int.)
2,3-Dimethyl-4-Nitropyridine N-Oxide [37699-43-7] (Lansoprazole Int.)
2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine hydrochloride [103577-66-8] (Lansoprazole Int.)
2-chloromethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine hydrochloride [127337-60-4] (Lansoprazole Int.)
2-[[3-methyl-4-(2,2,2--Trifluoroethoxy)-2-Pyridiline]-Thio-1H]-Benzimidazole [103577-40-8] (Lansoprazole Int.)
1, 1 - Thiomethyl Cyclopropane Acetic Acid [162515-68-6] (Montelukast Int.)
Methyl 1-(Mercaptomethyl)cyclopropaneacetate 152922-73-1 (Montelukast Int.)
(S)-1-(3-(2-(7-Chloro 2 Quinolinyl)Ethenyl)Phenyl)-3-(2-
(1-Hydroxy-1-Methyl Ethyl)-Phenyl) Propanol [142569-70-8] (Montelukast Int.)
2-Chloromethyl-3,5-dimethyl-4-methoxy pyridine hydrochloride [86604-75-3] (Omeprazole /
Esomeprazole Int.)
5-Methoxy-2-(4-methoxy -3,5- dimethylpyridine-2yl)
methylthio)- 1H-Benzimidazole [73590-85-9] (Omeprazole /
Esomeprazole Int.)
5-[[4-[2-(Methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2-imino- 4-thiazolidinone [329249-53-8] (Rosiglitazone Int.)
5-[[4-[2-(Methyl-2-pyridinylamino)ethoxy]phenyl]methylene]-2,4- thiazolidinedione [122320-74-5] (Rosiglitazone Int.)
(6R,12aR)-methyl 1,2,3,4-tetrahydro-2-chloroacetyl-1-(3,4-
methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate [171489-59-1] (Tadalafil Int.)
PHARMACEUTICAL FORMULATIONS
We also offer a wide range of pharmaceutical formulations in conventional as well as advanced dosage forms
Tablets
Capsules
Liquids
Metered Dose Inhalers
Nasal Sprays
External Aerosols
New products and combination drugs other than those appearing in our standard product list and restricted to the above dosage forms can be developed in short time cycles and offered accordingly. Dossier support offered for most of our products.
(The above dosage forms are grouped under the Therapeutic Areas such as - CARDIOVASCULAR SYSTEM, BETA BLOCKERS, ANTIHYPERTENSIVES, ANTI ANGINAL, ANTI PLATELET, DIURETICS, HYPOLIPIDAEMIC AGENTS, MUSCULO SKELETAL DISORDER, OPIOID & NONOPIOID ANALGESICS, MUSCLE RELAXANTS, ANTIBIOTICS, ANTI TUBERCULAR, MACROLIDES, QUINOLONES, SULPHONAMIDE, ANTIFUNGALS, ANTI MALARIALS, CENTRAL NERVOUS SYSTEM, SEDATIVES , ANTI DEPRESSANTS, ANTI HYPOTENSIVE, ALIMENTARY SYSTEM, ANTACIDS, H2 BLOCKERS &ANTI ULCERS ,ANTI DIARRHOEALS, ANTI ALLERGICS, ANTI HISTAMINE, INHALERS, NASAL DECONGESTANT SPRAYS, CORTICOSTEROIDS, ORAL ANTIDIABETIC AGENTS, METABOLISM, ANTI OSTEOPOROSIS, NSAIDS, VITAMINS, ERECTILE DYSFUNCTION, HIV ANTI VIRALS, PROTOZOAL INFESTATIONS, ANTHELMINTICS.
Please let us know if you are interested in our product range. We will be pleased to quote our best services to you & build a longterm business relation with your esteemed company.
We look forward to your positive reply.
Best Regards,
Ms. Raj Kaur
Sales Officer
-----------------------------------------------------------------
Ultratech India Ltd.
Regd. off.: 113, J. K. Chambers,
Sector-17, Vashi,
Navi Mumbai- 400 705, India.
Tel: +91-22-27892736 / 27893593 / 27891443
Fax: +91-22-27892734
Email: ***
Visit us at: ***
====================================
PATENTS:
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1)
===========================================================================